SC 13D/A 1 f13da_3q-2001.txt SCHEDULE 13D/A AMENDMENT NO. 1 CUSIP No. 141410 20 9 Page 1 of 8 Pages SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 1)1 Cardiac Science, Inc. ------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 par value ------------------------------------------------------------------------------- (Title of Class of Securities) 141410 20 9 ------------------------------------------------------------------------------- (CUSIP Number) Kathleen K. Schoemaker John C. MacMurray, Esq. Domain Associates, L.L.C. Reboul, MacMurray, Hewitt, One Palmer Square Maynard & Kristol Princeton, New Jersey 08452 45 Rockefeller Plaza Tel. (609) 683-5656 New York, New York 10111 Tel. (212) 841-5700 ------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) September 13, 2001 ------------------------------------------------------------------------------- (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [ ]. -------- 1The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 141410 20 9 Page 2 of 8 Pages 1) Name of Reporting Person Domain Partners I.R.S. Identification IV, L.P. No. of Above Person (If an Entity) ------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [x] if a Member of a Group (b) [ ] ------------------------------------------------------------------------------- 3) SEC Use Only ------------------------------------------------------------------------------- 4) Source of Funds WC ------------------------------------------------------------------------------- 5) Check if Disclosure of Legal Proceedings is Not Applicable Required Pursuant to Items 2(d) or 2(e) ------------------------------------------------------------------------------- 6) Citizenship or Place of Organization Delaware ------------------------------------------------------------------------------- Number of 7) Sole Voting 5,969,169 shares of Shares Beneficially Power Common Stock Owned by Each Reporting Person With ------------------------------------------- 8) Shared Voting Power -0- ------------------------------------------- 9) Sole Disposi- 5,969,169 shares of tive Power Common Stock ------------------------------------------- 10) Shared Dis- positive Power -0- ------------------------------------------- 11) Aggregate Amount Beneficially 5,969,169 shares of Owned by Each Reporting Person Common Stock ---------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares ---------------------------------------------------------------------------- 13) Percent of Class Represented by 18.7% Amount in Row (11) ---------------------------------------------------------------------------- 14) Type of Reporting Person PN CUSIP No. 141410 20 9 Page 3 of 8 Pages 1) Name of Reporting Person DP IV Associates, I.R.S. Identification L.P. No. of Above Person (If an Entity) ------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [x] if a Member of a Group (b) [ ] ------------------------------------------------------------------------------- 3) SEC Use Only ------------------------------------------------------------------------------- 4) Source of Funds WC ------------------------------------------------------------------------------- 5) Check if Disclosure of Legal Proceedings is Not Applicable Required Pursuant to Items 2(d) or 2(e) ------------------------------------------------------------------------------- 6) Citizenship or Place of Organization Delaware ------------------------------------------------------------------------------- Number of 7) Sole Voting 141,942 shares of Shares Beneficially Power Common Stock Owned by Each Reporting Person With ------------------------------------------- 8) Shared Voting Power -0- ------------------------------------------- 9) Sole Disposi- 141,942 shares of tive Power Common Stock ------------------------------------------- 10) Shared Dis- positive Power -0- ------------------------------------------- 11) Aggregate Amount Beneficially 141,942 shares of Owned by Each Reporting Person Common Stock ------------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares ------------------------------------------------------------------------------- 13) Percent of Class Represented by 0.4% Amount in Row (11) ------------------------------------------------------------------------------- 14) Type of Reporting Person PN CUSIP No. 141410 20 9 Page 4 of 8 Pages 1) Name of Reporting Person Domain Partners I.R.S. Identification III, L.P. No. of Above Person (If an Entity) ------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [x] if a Member of a Group (b) [ ] ------------------------------------------------------------------------------- 3) SEC Use Only ------------------------------------------------------------------------------- 4) Source of Funds Not Applicable ------------------------------------------------------------------------------- 5) Check if Disclosure of Legal Proceedings is Not Applicable Required Pursuant to Items 2(d) or 2(e) ------------------------------------------------------------------------------- 6) Citizenship or Place of Organization Delaware ------------------------------------------------------------------------------- Number of 7) Sole Voting 798,071 shares of Shares Beneficially Power Common Stock Owned by Each Reporting Person With ------------------------------------------- 8) Shared Voting Power -0- ------------------------------------------- 9) Sole Disposi- 798,071 shares of tive Power Common Stock ------------------------------------------- 10) Shared Dis- positive Power -0- ------------------------------------------- 11) Aggregate Amount Beneficially 798,071 shares of Owned by Each Reporting Person Common Stock ------------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares ------------------------------------------------------------------------------- 13) Percent of Class Represented by 2.5% Amount in Row (11) ------------------------------------------------------------------------------- 14) Type of Reporting Person PN CUSIP No. 141410 20 9 Page 5 of 8 Pages 1) Name of Reporting Person DP III Associates, I.R.S. Identification L.P. No. of Above Person (If an Entity) ------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [x] if a Member of a Group (b) [ ] ------------------------------------------------------------------------------- 3) SEC Use Only ------------------------------------------------------------------------------- 4) Source of Funds Not Applicable ------------------------------------------------------------------------------- 5) Check if Disclosure of Legal Proceedings is Not Applicable Required Pursuant to Items 2(d) or 2(e) ------------------------------------------------------------------------------- 6) Citizenship or Place of Organization Delaware ------------------------------------------------------------------------------- Number of 7) Sole Voting 21,285 shares of Shares Beneficially Power Common Stock Owned by Each Reporting Person With ------------------------------------------------------------------------------- 8) Shared Voting Power -0- ------------------------------------------------------------------------------- 9) Sole Disposi- 21,285 shares of tive Power Common Stock ------------------------------------------------------------------------------- 10) Shared Dis- positive Power -0- ------------------------------------------------------------------------------- 11) Aggregate Amount Beneficially 21,285 shares of Owned by Each Reporting Person Common Stock ------------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares ------------------------------------------------------------------------------- 13) Percent of Class Represented by less than 0.1% Amount in Row (11) ------------------------------------------------------------------------------- 14) Type of Reporting Person PN CUSIP No. 141410 20 9 Page 6 of 8 Pages Amendment No. 1 to Schedule 13D Reference is hereby made to the statement on Schedule 13D filed with the Securities and Exchange Commission on August 29, 2000 (the "Schedule 13D"). Terms defined in the Schedule 13D are used herein as so defined. The Schedule 13D is hereby amended as follows: Item 3. Source and Amount of Funds or Other Consideration. Item 3 is hereby amended by adding the following thereto: This statement relates to the acquisitions by DP IV and DP IV A on September 13, 2001 and September 24, 2001 of an aggregate 5,000,000 shares of Common Stock (the "September 2001 Shares") pursuant to a Subscription Agreement with the Issuer (the "Subscription Agreement"). The Form of Subscription Agreement is attached hereto as Exhibit A, and any description thereof is qualified in its entirety by reference thereto. The purchase price was $2.00 per Share, and the source of such funds was the working capital, or funds available for investment, of DP IV and DP IV A. Item 5. Interest in Securities of the Issuer. Item 5 is hereby amended and restated to read in its entirety as follows: The following information is based on a total of 31,962,787 shares of Common Stock represented by the Issuer to be outstanding as of September 26, 2001: (a) DP III DP III owns 798,071 shares of Common Stock, or approximately 2.5% of the Common Stock outstanding. OPSA III, as the general partner of DP III, may be deemed to beneficially own the shares of Common Stock owned by DP III. DP III A DP III A owns 21,285 shares of Common Stock, or less than 0.1% of the Common Stock outstanding. OPSA III, as the general partner of DP III A, may be deemed to beneficially own the shares of Common Stock owned by DP III A. DP IV DP IV owns 5,969,169 shares of Common Stock, or approximately 18.7% of the Common Stock outstanding. OPSA IV, as the general partner of DP IV, may be deemed to beneficially own the shares of Common Stock owned by DP IV. CUSIP No. 141410 20 9 Page 7 of 8 Pages DP IV A DP IV A owns 141,942 shares of Common Stock, or approximately 0.4% of the Common Stock outstanding. OPSA IV, as the general partner of DP IV A, may be deemed to beneficially own the shares of Common Stock owned by DP IV A. (b) The general partners of OPSA III and managing members of OPSA IV may be deemed to share the power to vote or direct the voting of and to dispose or to direct the disposition of the Common Stock owned by DP III, DP III A, DP IV and DP IV A. Each of the general partners of OPSA III and managing members of OPSA IV disclaims beneficial ownership of all shares of Common Stock other than the shares of Common Stock he or she may own directly, if any, or by virtue of his or her indirect pro rata interest, as a general partner of OPSA III and/or managing member of DP IV A, in the Common Stock owned by DP III, DP III A, DP IV and/or DP IV A. (c) Except as described in Item 3 above, none of the entities or individuals identified in Item 2 of the Schedule 13D has effected any transaction in the Common Stock during the past 60 days. (d) Except as described in this statement, no person has the power to direct the receipt of dividends on, or the proceeds from sales of, the shares of Common Stock owned by DP III, DP III A, DP IV or DP IV A. (e) Not applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. Pursuant to the Subscription Agreement, the Issuer has agreed to file a registration statement on Form S-3 covering the resale of the September 2001 Shares within 45 days from the date of the second closing, as defined in therein, and to grant certain "piggy back" registration rights with respect to such shares. Item 7. Material to be Filed as Exhibits. Exhibit A - Subscription Agreement CUSIP No. 141410 20 9 Page 8 of 8 Pages Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: October 3, 2001 DOMAIN PARTNERS III, L.P. By: One Palmer Square Associates III, L.P., General Partner By /s/ Kathleen K. Schoemaker ------------------------------ General Partner DP III ASSOCIATES, L.P. By: One Palmer Square Associates III, L.P., General Partner By /s/ Kathleen K. Schoemaker ------------------------------ General Partner DOMAIN PARTNERS IV, L.P. By: One Palmer Square Associates IV, L.L.C., General Partner By /s/ Kathleen K. Schoemaker ------------------------------ Managing Member DP IV ASSOCIATES, L.P. By: One Palmer Square Associates IV, L.L.C., General Partner By /s/ Kathleen K. Schoemaker ------------------------------ Managing Member